The Potential of Caffeine for Functional Modification from Cortical Synapses to Neuron Networks in the Brain
Journal:
Current Neuropharmacology
Volume:
3
Page:
309-316
Author(s):
H. Yoshimura
PET Imaging in Clinical Drug Abuse Research
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3203-3219
Author(s):
S. J. Gatley, N. D. Volkow, G.- J. Wang, J. S. Fowler, J. Logan, Y.- S. Ding and M. Gerasimov
Anesthetics as Chemical Tools to Study the Structure and Function of Nicotinic Acetylcholine Receptors
Journal:
Current Protein & Peptide Science
Volume:
6
Page:
451-472
Author(s):
Hugo R. Arias and Pankaj Bhumireddy
Cannabinoids
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
507-530
Author(s):
Franjo Grotenhermen
Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
553-567
Author(s):
Daniela Fenili and JoAnne McLaurin
Antiepileptics and the Treatment of Neuropathic Pain: Evidence from Animal Models
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2961-2976
Author(s):
G. Blackburn-Munro and H. K. Erichsen
Positron Emission Tomography: Applications In Drug Discovery and Drug Development
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1053-1075
Author(s):
Jingli Wang and Laura Maurer
Crosstalk Between Calpain and Calcineurin in Excitotoxic Neurodegeneration; Therapeutic Targets for the Treatment of Excitotoxic Neurodegeneration
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
5
Page:
207-216
Author(s):
Hai-Yan Wu, Hideki Matsui and Kazuhito Tomizawa
CAR, The Continuously Advancing Receptor, in Drug Metabolism and Disease
Journal:
Current Drug Metabolism
Volume:
6
Page:
329-339
Author(s):
M. Qatanani and D. D. Moore
The Role of Newer Antiglutamatergic Agents as Mood-Stabilizers in Bipolar Disorder
Journal:
Current Drug Targets
Volume:
6
Page:
607-614
Author(s):
Marianna Abelli, Claudia Martini, Stefano Pini, Camilla Gesi and Giovanni B. Cassano